A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...
Stocktwits on MSN
Anktiva vs Keytruda: ImmunityBio exec chair slams FDA for double standards in approvals
ImmunityBio Executive Chairman Patrick Soon-Shiong criticized the FDA for applying tougher approval standards to Anktiva than to Merck’s Keytruda. ・He said regulators allowed Keytruda to expand across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results